Company Overview and News
Tags / Keywords: Corporate News , M&A , Chemical Company of Malaysia Bhd , CCM Duopharma Biotech Bhd (0-1)
MarketWatch: The S&P 500 and the Nasdaq fell on Thursday, weighed down by Amazon.com, Apple and other top-shelf technology stocks, while the Dow Jones Industrial Average edged up to a seventh straight record high. The DJIA edged up 0.04%, or 9.86 points, to end at 22,026.1, an all-time high. The S&P 500 lost 0.22% to 2,472.16 and the Nasdaq dropped 0.35% to 6,340.34. - Reuters
MarketWatch: The Dow climbed above the 22,000 mark for the first time on Wednesday, buoyed by Apple's healthy quarterly iPhone sales, while weakness in other tech stocks held back the Nasdaq and S&P 500. The DJIA rose rose 0.24% to end at 22,016.24, a record high. The S&P 500 gained 0.05% to 2,477.57 and the Nasdaq was flat at 6,362.65. - Reuters
Tags / Keywords: Corporate News , M&A , Chemical Co of Malaysia Bhd , CCM Duopharma Biotech Bhd
KUALA LUMPUR, Aug 2 — Gains in heavyweights pushed the benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) to end higher at mid-day today, amid weak sentiment in the broader market.
Trading in CCM Duopharma Biotech Bhd and Chemical Company of Malaysia Bhd were voluntarily suspended on Wednesday.
KUALA LUMPUR (April 3): Based on corporate announcements and news flow today, stocks that may be in focus on Tuesday (April 4) may include: Eco World International Bhd, Tenaga Nasional Bhd, Felda Global Ventures Holdings Bhd, Yinson Holdings Bhd, GHL Systems Bhd, CCM Duopharma Biotech Bhd, Kelington Group Bhd, MMC Corporation Bhd and Alam Maritim Resources Bhd
A worker is seen at a construction site, with the Malaysia's landmark Petronas Twin Towers in the background, in Kuala Lumpur September 12, 2013. – Reuters picKUALA LUMPUR, March 2 — Promising developments at CCM Duopharma Biotech Berhad (CCMD) put the firm in position to become Malaysia’s leading biosimilar producer, according to a BMI Research note today.
CCM Duopharma Biotech Bhd (CCMDB) and PanGen Biotech, Inc. have completed their clinical trials for the biosimilar erythropoietin or EPO product which can be used in kidney dialysis.
KUALA LUMPUR (Feb 15): CCM Duopharma Biotech Bhd will begin the registration for commercialisation of its erythopoietin (EPO) biosimilar, which will be beneficial in the treatment of anaemia in end-stage kidney failure patients.
PETALING JAYA: The Chemical Company of Malaysia Bhd (CCM), which recently received certification to produce halal pharmaceutical products, is looking to turn around its fortunes after two years of chalking up losses.
MarketWrap: US stocks climbed on Wednesday and the Dow Jones Industrial Average closed atop the 20,000 mark for the first time as solid earnings and optimism over President Donald Trump's pro-growth initiatives revitalised a post-election rally. - Reuters The DJIA rose 155.80 points, or 0.78%, to close at 20,068.51, the S&P 500 gained 18.30 points, or 0.80%, to 2,298.37 and the Nasdaq added 55.38 points, or 0.
KUALA LUMPUR (Jan 26): The FBM KLCI is expected to extend its gains today riding on the overnight momentum at most global markets.
KUALA LUMPUR (Jan 25): Based on corporate announcements and news flow today, stocks in focus tomorrow could include Spritzer Bhd, IGB Real Estate Investment Trust, Genting Plantations Bhd, Hua Yang Bhd, Magna Prima Bhd, Gadang Holdings Bhd, Zhulian Corp Bhd, CCM Duopharma Biotech Bhd and Stone Master Corp Bhd. Spritzer Bhd, famous for its bottled mineral water products, reported a net profit of RM5.
KUALA LUMPUR (Jan 25): CCM Duopharma Biotech Bhd announced that its wholly-owned subsidiary, CCM Pharmaceuticals Sdn Bhd, has been awarded a RM300.04 million contract by the Health Ministry to supply human insulin to all government hospitals and clinics in Malaysia. In a filing with Bursa Malaysia this afternoon, CCM Duopharma said the contract is valid for three years, which had commenced from Dec 2, 2016, and will last until Dec 1, 2019.
11h - Wilton
2017-12-03 - Wilton
2017-11-27 - Wilton